EMFLAZA 22.75 mg/mL
deflazacort · SUSPENSION · PTC Therapeutics, Inc.
Emflaza is an oral corticosteroid suspension used to treat Duchenne muscular dystrophy in pediatric patients. It works by reducing inflammation and suppressing immune system activity to help slow muscle weakness progression.
Key Facts
- Brand Name
- EMFLAZA
- Generic Name
- deflazacort
- NDC Code (Product)
52856-505- Manufacturer
- PTC Therapeutics, Inc.
- Strength
- 22.75 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA208685
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 09/10/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is EMFLAZA used for?
Emflaza is an oral corticosteroid suspension used to treat Duchenne muscular dystrophy in pediatric patients. It works by reducing inflammation and suppressing immune system activity to help slow muscle weakness progression.
Is EMFLAZA a controlled substance?
EMFLAZA is not classified as a controlled substance by the DEA.
What is the generic name for EMFLAZA?
The generic name for EMFLAZA is deflazacort. There are 10 other brand versions of deflazacort.
What is the NDC code for EMFLAZA 22.75 mg/mL?
The NDC (National Drug Code) for EMFLAZA 22.75 mg/mL is 52856-505, listed by PTC Therapeutics, Inc..